This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
ESBBMentoring

ESBB Mentoring 

Our ESBB Mentoring Program enables personal growth and helps to promote individual careers through an open bilateral exchange of knowledge and experience between mentee and mentor. Take advantage of the experiences of expert biobankers, seek their strategic advice and/or benefit from their professional networks. This is particularly intended for students and young biobankers in their early career. First comes first serve: register to become a mentee in the group of your preferred mentor by contacting our ESBB office with a paragraph of motivation, your short CV and your desired mentor selection. 

 

ESBB Leadership Mentors

Dr. Ronny Baber

Leipzig Medical Biobank – University Leipzig Germany


"Biobanks will gain importance in the upcoming years. I'm happy to share my experience and give insight in setting up and leading a biobank and everything around these topics." 

Curriculum Vitae

Dr. Ronny Baber works in the Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics at the University Hospital Leipzig. He is the head of the Leipzig Medical Biobank and the LIFE-Preanalytical laboratory in the Leipzig Research Center for Civilisation Diseases (LIFE). Dr. Baber is a member of the working group in the German Institute for Standardization (DIN) which supports the ISO TC 276 responsible for the ISO norm 20387 on biobanking and BBMRI-ERIC workgroups for the evaluation of CEN standards. He is also part of the Steering Committee and different working groups in the “German Biobank Alliance” (GBA) initiated and coordinated by BBMRI.de trying to link GBA biobanks to the BBMRI-ERIC infrastructure. Since September 2017 he is designated as Treasurer of the ESBB.

Dr. Paul Bartels 

Tshwane University of Technology
South Africa

“I’d be happy to share with my mentees the experiences I obtained regarding the establishment of a wildlife / biodiversity Biobank, selection criteria for master-/PhD-thesis topics, networking possibilities and/or other topics we discover together to be of high importance for your carrier advancement.” 

Curriculum Vitae

Dr. Bartels qualified as a veterinarian and went on to complete a Master’s degree in Zoology. He started the Wildlife Biological Centre (wBRC) as a working group of the Endangered Wildlife Trust which as later transferred to the National Research Foundation. The wBRC later became known as the NZG Biobank. Dr. Bartels has extensive experience in wildlife management, including game capture and translocation of wildlife. He is the recipient of the following awards: Mazda Wildlife Fund top South Africa conservationist of the decade; Wildlife and Environment Society of SA (WESSA) lifetime achievement Award; National Science and Technology Forum’s Science Engineering & Technology Award. 
Dr. Bartels is a board member of the Magaliesberg Biosphere Reserve and a past member of ISBER and WESSA. He was Councillor of ESBB and is now ESBB Ambassador. 
In 2014, Dr. Bartels joined the Department of Nature Conservation of the Tshwane University of Technology where he teaches undergraduate courses and supervises post-graduate students. In 2017, he was the recipient of the African Entrepreneurship Award.

Prof. Sofie Bekaert

Flemish Institute for Biotechnology Ghent
Belgium

“I’d be happy to share with my mentees the experiences I obtained regarding biobank and translational research career options in academia and beyond, networking possibilities and/or other topics we discover together to be of high importance for your carrier advancement.”

Curriculum Vitae

Sofie Bekaert is currently Manager of the Translational Program at the Flemish Interuniversity Institute for Biotechnology (VIB), where she coordinates the Grand Challenges Program and in addition is part-time senior lecturer at the Faculty of Medicine and Health Sciences from Ghent University. 
Prof. Sofie Bekaert was trained as a doctor in Applied Biological Engineering. After 10 y of research, setting up a research platform on biological aging, next generation sequencing and biomarkers, she became valorization and innovation manager at Ghent University. In 2010 she initiated the Clinical Research Center at Ghent University Hospital.  As the head of Bimetra, she had the responsibility over a dedicated team in the daily management of the central point of contact for facilitation of different aspects of translational biomedical research (ethico-legal aspects, data management and monitoring of clinical trials, research and innovation management within the hospital, biobanking, big data). 
Prof. Bekaert is liaising to strategic translational initiatives concerning biobanking and clinical research and innovation, both at the regional and (inter)national level. Between 2017-2019 she was appointed president of the Board of directors of the BBMRI.be, the Belgian node within the European biobank infrastructure network and she is involved in multiple societal valorization projects concerning stakeholder involvement and participation in research (e.g. Eupati, King Baudouin Foundation – multistakeholder dialogue for prioritization of research). Prof. Bekaert is currently ESBB Councillor.
Kristin Goldring

R&D Oncology Unit, Astra Zeneca
Great Britain

“I’d be happy to share with my mentees the experiences I obtained regarding biobank career options in both academia and industry, networking possibilities and/or other topics we discover together to be of high importance for your carrier advancement.”

Curriculum Vitae

Kirstin Goldring graduated in Physiology and Pharmacology (BSc) and completed her PhD on asthma research at Southampton University. She joined AstraZeneca in January 2015 in the role of Principal Scientist: Human Biological Sample Governance and Strategy. Kirstin works with the biobanks globally to ensure that AstraZeneca scientists can access the samples and data that they need in a compliant way. Kirstin Goldring has worked in the Biobanking field for over 17 years in different roles and sectors. She managed the set up and development of the UK Parkinson’s Disease Society Tissue Bank at Imperial College from 2002 until 2009. From 2009-2012 she was the Biobank facilitator at UCL. The role involved in developing biobank infrastructure and support, and providing advice on protocols, ethics and regulations for use of human samples. From 2012, the role expanded to co-ordinate the UCL BioResource project. Kirsten Goldring is currently Councillor of ESBB.


Prof. Jens K. Habermann, M.D., Ph.D.

University of Lübeck & University Clinic Schleswig-Holstein
Germany

“I’d be happy to share my experiences regarding biobank and translational cancer research career options in academia, selection criteria for thesis topics, networking possibilities and/or other topics we together identify to be of importance for your carrier advancement.”  

Curriculum Vitae

Jens K. Habermann received his training as Medical Doctor at the University of Lübeck, Germany. He obtained his Ph.D. at the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden, and received a postdoctoral fellowship at the National Cancer Institute, NIH, Bethesda, USA. In 2012, Jens K. Habermann received his Professorship at the University of Lübeck and University Hospital Schleswig-Holstein, Campus Lübeck, Germany. He works clinically as board certified specialist in human genetics, is Head of the Laboratory for Translational Surgical Oncology and Biobanking, Scientific Director of the University Cancer Center Lübeck, and University representative and Head of the Interdisciplinary Center for Biobanking-Lübeck (ICB-L). Combining clinical routine, biobanking, and cancer research, he focuses to optimize precision medicine by determining genome instability, targeting tumor heterogeneity and applying liquid biopsies.

Jens K. Habermann has become ESBB member after participating at the ESBB inauguration meeting in Marseille 2011. He has served as Councillor before being elected as President-Elect. Jens K. Habermann is currently President of ESBB and also Board Member and Representative of the German Biobank Alliance (GBA).  

Dr. Rita Lawlor

ARC-NET, University of Verona
Italy

“Biobanking is woven into the fabric of good scientific research and I am happy to share my experience and that of my cancer biobank and applied research centre to those interested in entering this field.”

Curriculum Vitae

Rita T. Lawlor is a Computer Science graduate with a doctorate in Oncological Pathology. She is co-founder of the ARC-Net applied cancer research centre and is director of the ARC-Net biobank, coordinating research activities. She is a member of the steering committee of BC-NET (Biobank Cohort Network of Low Middle Income Countries) of IARC (International Association for Research on Cancer). She is a former director of ISBER, past-president of ESBB and currently ESBB Ambassador. She is IAPP (International Association of Privacy Professionals) CIPP/E and CIPM certifications for European data protection and is chair of the ISBER GDPR Task Force. 
Dr. Lawlor’s current research interests are in molecular diagnostic markers and therapeutic targets and the role of cancer heterogeneity and molecular characterization of samples in the application of individualized medicine. 

Dr. Barbara Parodi

IRCCS Ospedale Policlinico San Martino, Genoa
Italy

“I’d be happy to share with my mentees my expertise regarding Good Cell Culture Practices and cell line authentication, as I believe cell line poor quality and mis-identification to be a major issue in biomedical research.”

Curriculum Vitae

Dr. Barbara Parodi, medical doctor, executive manager of the Biological Resource Centre of the IRCCS Ospedale Policlinico San Martino (CRB-HSM) of Genoa, Italy. I have been deeply involved in biobanking for many years, dealing with scientific, organizational, technical and ethical issues. My expertise is mainly in management, quality assurance and quality control in biobanks and biomolecular resources. I take part in the Steering Committee of BBMRI.it, the Italian National node of BBMRI-ERIC, with the role of project manager, chair of the Biobank evaluation committee and responsible of the common service quality, and I participate in several BBMRI-ERIC working groups on quality. I have participated in the OECD Task Force on BRCs (2001-2007) and I served as ESBB treasurer (2014-2017) and as ESBB liaison to ISO/TC 276 Biotechnology (2016-2017). I am currently ESBB Ambassador.

Dr. Peter H. J. Riegman

Erasmus Medical Center Rotterdam
The Netherlands

“I’d be happy to share with my mentees the experiences I obtained regarding the establishment of a wildlife / biodiversity Biobank, selection criteria for master-/PhD-thesis topics, networking possibilities and/or other topics we discover together to be of high importance for your carrier advancement.” 

Curriculum Vitae

Dr. Peter Riegman is a molecular biologist. 1982-1986: Biology Leiden University; 1986-1992: Ph.D. study on Prostate-Specific Antigen at Erasmus University Rotterdam; Promotor: Prof. Dr. D. Bootsma, Co-promotor: Prof. Dr. J. Trapman; 1992-1997: Postdoc on meningioma and neurofibromatosis at Erasmus University Rotterdam; Dr. E. Zwarthoff; 1997-2001: Postdoc on neoplastic progression in Barrett’s Esophagus at Erasmus University, Rotterdam; Dr. H. van Dekken; 2001 – present: Head of the Erasmus MC Tissue Bank Pathology Dept., Erasmus Medical Center, Rotterdam, where he became involved in European projects: EurocanPlatform, BIOPOOL, SPIDIA4P, BBMRI, EuroBoNeT and TuBaFrost coordinator. Since 2017 active in SPIDIA4P. 2010 ISBER president. ESBB president in 2011 and Section editor of Biopreservation and Biobanking. From 2012 Erasmus MCPSI UMC coordinator and NEN commissioner in CEN/TC140WG3 and ISO/TC212WG4. 2018 advisor project team Erasmus MC Central Biobank. Dr. Riegman is ESBB Ambassador.

Prof. Elke Smits

Science & Innovation Dept., Antwerp University Hospital
Belgium

“I’d be happy to share with my mentees the experiences I obtained regarding biobank and translational research career options in academia and beyond, networking possibilities and/or other topics we discover together to be of high importance for your carrier advancement.”

Curriculum Vitae

Prof. Elke Smits earned her Bachelor of Science in Chemistry from the University of Leuven, a Master of Science in Biotechnology and a PhD in Veterinary Sciences in 1998 from the University of Gent in Belgium. She joined Devgen Inc, a spin-off company in Gent, as manager molecular cell biology for target discovery and drug development projects. In 2004, she became senior scientist at the Flemish Science Policy Council, the advisory body for the Flemish regional government concerning science and innovation policy. She has published over 20 peer-reviewed articles, holds several patents, wrote many policy advices and recommendations and authored the study series Technology and Innovation in Flanders: Priorities. Prof. Dr. Elke Smis currently heads the Science & Innovation Department of the Antwerp University Hospital in Belgium and has gained extensive experience in merging translational research and biobanking within a clinical setting. She holds a visiting professorship position at the Faculty of Medicine of the University of Antwerp and is liaison officer of the Clinical Research Center Antwerp.
As ESBB Ambassador, Prof. Elke Smits promotes ESBB. She served for a term as ESBB Councillor, president-elect, president, and past-president. She also started the ESBB working group Academic & Industry Cooperation (formally “ESBBTranslate”) with Christina Schroeder from Fraunhofer Institute in Germany and Eoin Gaffney, Pathologist and founder of the Biobank Ireland Trust.